Attenuation of endothelin-1-induced calcium response by tyrosine kinase inhibitors in vascular smooth muscle cells

American Journal of Physiology - Cell Physiology

Volumn 270, Issue 6 39-6, 1996, Pages

  Liu, Cynthia Y ^a   Sturek, Michael ^a  

^a NONE

Author keywords

caffeine; fura 2; genistein; inositol trisphosphate; methyl 2,5 dihydroxycinnamate; sarcoplasmic reticulum; whole cell current

Indexed keywords

CAFFEINE; CALCIUM ION; ENDOTHELIN 1; FURA 2; GENISTEIN; INOSITOL TRISPHOSPHATE; METHYL 2,5 DIHYDROXYCINNAMATE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; CORONARY ARTERY; ENZYME ACTIVATION; MICROFLUOROMETRY; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; SWINE; VASCULAR SMOOTH MUSCLE;

EID: 0029769297     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.1996.270.6.c1825     Document Type: Article

References (38)

1. Abebe, W., and D. K. Agrawal. Role of tyrosine kinases in norepinephrine-induced contraction of vascular smooth muscle. J. Cardiovasc. Pharmacol. 26: 153-159, 1995.
2. Bobik, A., A. Grooms, J. A. Millar, A. Mitchell, and S. Grinpukel. Growth factor activity of endothelin on vascular smooth muscle. Am. J. Physiol. 258 (Cell Physiol. 27): C408-C415, 1990.
3. Bokoch, G. M., and C. J. Der. Emerging concepts in the Ras superfamily of GTP-binding proteins. FASEB J. 7: 750-759, 1993.
4. Bourne, H. R., and L. Stryer. The target sets the tempo. Nature Lond. 358: 541-543, 1995.
5. 2+ channel antagonists. Trends Pharmacol. Sci. 13: 256-262, 1992.
6. α subunits that interact with Gβγ, receptors, and effectors. Cell 73: 631-641, 1993.
7. Dhar, A., and S. D. Shukla. Tyrosine kinases in platelet signalling. Br. J. Haematol. 84: 1-7, 1993.
8. c-src kinase activity in extracts from vascular smooth muscle. J. Biol. Chem. 264: 10773-10778, 1989.
9. 2+ sensitivity for contraction of smooth muscle. Can. J. Physiol. Pharmacol. 72: 1434-1439, 1994.
10. Fleming, I., B. Fisslthaler, and R. Busse. Calcium signaling in endothelial cells involves activation of tyrosine kinases and leads to activation of mitogen-activated protein kinases. Circ. Res. 76: 522-529, 1995.
11. 2+ mobilization in swine carotid media. Am. J. Physiol. 268 (Cell Physiol. 37): C1425-C1429, 1995.
12. Highsmith, R. F., K. Blackburn, and D. J. Schmidt. Endothelin and calcium dynamics in vascular smooth muscle. Annu. Rev. Physiol. 54: 257-277, 1992.
13. Hollenberg, M. D. Tyrosine kinase pathways and the regulation of smooth muscle contractility. Trends Pharmacol. Sci. 15: 108-114, 1994.
14. Kasuya, Y., Y. Takuwa, M. Yanagisawa, T. Masaki, and K. Goto. A pertussis toxin-sensitive mechanism of endothelin action in porcine coronary artery smooth muscle. Br. J. Pharmacol. 107: 456-462, 1992.
15. Katoch, S. S., and R. S. Moreland. Agonist and membrane depolarization induced activation of MAP kinase in the swine carotid artery. Am. J. Physiol. 269 (Heart Circ. Physiol. 38): H222-H229, 1995.
16. Koide, M., Y. Kawahara, T. Tsuda, Y. Ishida, K. Shii, and M. Yokoyama. Endothelin-1 stimulates tyrosine phosphorylation and the activities of two mitogen-activated protein kinases in cultured vascular smooth muscle cells. J. Hypertens. 10: 1173-1182, 1992.
17. + current in arterial smooth muscle cells from aldosterone-salt hypertensive rats. Am. J. Physiol. 269 (Heart Circ. Physiol. 38): H1246-H1257, 1995.
18. cdc42. Nature Lond. 363: 364-367, 1993.
19. Marczin, N., A. Papapetropoulos, and J. D. Catravas. Tyrosine kinase inhibitors suppress endotoxin- and IL-1β-induced NO synthesis in aortic smooth muscle cells. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H1014-H1018, 1993.
20. Marrero, M. B., W. G. Paxton, J. L. Duff, B. C. Berk, and K. E. Bernstein. Angiotensin II stimulates tyrosine phosphorylation of phospholipase C-gamma 1 in vascular smooth muscle cells. J. Biol. Chem. 269:10935-10939, 1994.
21. Palade, P., C. Dettbarn, D. Brunder, P. Stein, and G. Hals. Pharmacology of calcium release from sarcoplasmic reticulum. J. Bioenerg. Biomembr. 21: 295-317, 1989.
22. Rana, R. S., and L. E. Hokin. Role of phosphoinositides in transmembrane signaling. Physiol. Rev. 70: 115-164, 1990.
23. Saifeddine, M., A. Laniyonu, S.-G. Yang, and M. D. Hollenberg. Tyrosine kinase inhibitors and the contractile action of angiotensin-II in vascular tissue. Pharmacol. Res. Commun. 1: 177-184, 1992.
24. B receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 89: 1203-1208, 1994.
25. Simonson, M. S., and W. H. Herman. Protein kinase C and protein tyrosine kinase activity contribute to mitogenic signaling by endothelin-1. J. Biol. Chem. 268: 9347-9357, 1993.
26. + currents by tyrosine kinase inhibitors genistein and ST 638. Circ. Res. 76: 310-316, 1995.
27. Stehno-Bittel, L., M. H. Laughlin, and M. Sturek. Exercise training alters Ca release from coronary smooth muscle sarcoplasmic reticulum. Am. J. Physiol. 259 (Heart Circ. Physiol. 28): H643-H647, 1990.
28. 2+ entry into acinar cells by a non-phosphorylatable inositol trisphosphate. Nature Lond. 352: 162-165, 1991.
29. Sturek, M., L. Stehno-Bittel, and P. K. Obye. Methods for simultaneous voltage-clamp, microfluorometry, and video of cells. II. Physiology. In: Electrophysiology and Ion Channels of Vascular Smooth Muscle Cells and Endothelial Cells, edited by N. Sperelakis and H. Kuriyama. New York: Elsevier, 1991, p. 269-294.
30. Takuwa, Y., Y. Kasuya, N. Takuwa, M. Kudo, M. Yanagisawa, K. Goto, T. Masaki, and K. Yamashita. Endothelin receptor is coupled to phospholipase C via a pertussis toxin-insensitive guanine nucleotide-binding regulatory protein in vascular smooth muscle cells, J. Clin. Invest. 85: 653-658, 1990.
31. Turner, C. E., K. M. Pietras, D. S. Taylor, and C. J. Molloy. Angiotensin II stimulation of rapid paxillin tyrosine phosphorylation correlates with the formation of focal adhesions in rat aortic smooth muscle cells. J. Cell Sci. 108: 333-342, 1995.
32. Ullrich, A., and J. Schlessinger. Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203-212, 1990.
33. Umezawa, K., T. Hori, H. Tajima, M. Imoto, K. Isshiki, and T. Takeuchi. Inhibition of epidermal growth factor-induced DNA synthesis by tyrosine kinase inhibitors. FEBS Lett. 260: 198-200, 1990.
34. 2+ in smooth muscle cells from bovine and porcine coronary artery: modulation of sarcoplasmic reticulum function. Br. J. Pharmacol. 105: 903-911, 1992.
35. Wagner-Mann, C., and M. Sturek. Endothelin mediates Ca influx and release in porcine coronary smooth muscle cells. Am. J. Physiol. 260 (Cell Physiol. 29): C771-C777, 1991.
36. Weber, H., M. L. Webb, R. Serafino, D. S. Taylor, S. Moreland, J. Norman, and C. J. Molloy. Endothelin-1 and angiotensin-II stimulate delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for common signaling mechanisms. Mol. Endocrinol. 8: 148-158, 1994.
37. Wijetunge, S., C. Aalkjaer, M. Schachter, and A. D. Hughes. Tyrosine kinase inhibitors block calcium channel currents in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 189: 1620-1623, 1992.
38. Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomobe, K. Mieko, R. Mitsui, Y. Yazaki, K. Goto, and T. Masaki. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature Lond. 332: 411-415, 1988.